Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder.

Annals of diagnostic pathology - 1 Oct 2015

Vail Eric, Zheng Xiaoyong, Zhou Ming, Yang Ximing, Fallon John T, Epstein Jonathan I, Zhong Minghao

Abstract excerpt

Glandular lesions of the urinary bladder include a broad spectrum of entities ranging from completely benign to primary and secondary malignancies. The accurate diagnosis of these lesions is both important and challenging. Recently, studies suggest that telomerase reverse transcriptase (TERT) pro...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoma
Share to Biomarkers, Tumor
Share to Cystitis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms, Glandular and Epithelial

Share to Polymerase Chain Reaction

Share to Promoter Regions, Genetic

Share to Telomerase

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 26239299
DOI: 10.1016/j.anndiagpath.2015.06.007

Genes

TERT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26239299-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Telomerase reverse transcriptase promoter mutations in glandular lesions of the urinary bladder.PMID 26239299Read ↗

Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation: pathogenesis and diagnostic implications.Semantic proximity Read ↗

Biological and clinical perspectives of TERT promoter mutation detection on bladder cancer diagnosis and management.Semantic proximity Read ↗

Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.Semantic proximity Read ↗

Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.Semantic proximity Read ↗

Emerging targets in upper tract urothelial carcinomas: the TERT gene.Semantic proximity Read ↗

Small-cell Carcinomas of the Urinary Bladder and Prostate: TERT Promoter Mutation Status Differentiates Sites of Malignancy and Provides Evidence of Common Clonality Between Small-cell Carcinoma of the Urinary Bladder and Urothelial Carcinoma.Semantic proximity Read ↗

TERT promoter mutations and methylation for telomerase activation in urothelial carcinomas: New mechanistic insights and clinical significance.Semantic proximity Read ↗

Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancer.Semantic proximity Read ↗

Distinguishing nested variants of urothelial carcinoma from benign mimickers by TERT promoter mutation.Semantic proximity Read ↗

High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.Semantic proximity Read ↗

Implications of TERT promoter mutations and telomerase activity in solid tumors with a focus on genitourinary cancers.Semantic proximity Read ↗

hTERT, hTR and TERT promoter mutations as markers for urological cancers detection: A systematic review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.